Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA grants approval for Taltz as treatment of active ankylosing spondylitis

Aug. 27, 2019

Medshine Discovery identifies Janus kinase inhibitors

Aug. 23, 2019

Identifying the cause of lupus cognitive dysfunction

Aug. 22, 2019

Placental growth factor may be autoimmune disease target

Aug. 22, 2019

PI3K-alpha tested as a therapeutic target for prevention of heterotopic ossification

Aug. 21, 2019

FDA approves Rinvoq for the treatment of moderate to severe rheumatoid arthritis

Aug. 19, 2019

Fast skeletal muscle troponin activators can counter skeletal muscle fatigue

Aug. 16, 2019

Pharmacological stabilization of TYK2 kinase could treat multiple immune-mediated diseases

Aug. 14, 2019

Good news, bad news macrophages identified in arthritis

Aug. 13, 2019

FDA approves Turalio as first therapy for rare and debilitating joint tumor

Aug. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...